All News

On this episode of the “Cancer Horizons” podcast, actress and comedian Jessica St. Clair and writer Dan O’Brien share their cancer stories and how they channeled their emotions through creativity.

A phase 2 trial of aspacytarabine (BST-236) was initiated in patients with AML and MDS.

Imbruvica plus Breyanzi, a CAR-T cell therapy, improved outcomes in patients with relapsed/refractory chronic lymphocytic leukemia, according to recent research.

An expert explains what treatment strategies are available for patients with metastatic breast cancer, how far research has come and why patients shouldn’t lose hope.

A cancer survivor describes the emotional rollercoaster of learning her tumor marker levels have risen. "I had decided that this would be the year I would bid farewell to my cancer journey. So much for my big plan," she writes.

Although the risk for myocarditis related to immune checkpoint inhibitors is an estimated 1%, findings from a recent study highlight the need for improved ways to screen and treat for this potential side effect.

Recent results may lead to more checkpoint inhibitor options and lower treatment prices, giving accessibility to more patients with lung cancer worldwide.

Imfinzi plus platinum-pemetrexed chemotherapy induced survival improvements in patients with previously untreated, unresectable malignant pleural mesothelioma, compared with chemotherapy alone.

The incidence of young-onset colorectal cancer has been increasing in the past years, and despite being more physically active and receiving more intense treatments, younger patients are not living longer with the disease than older patients.

A woman with ovarian cancer explains why she was reluctant to get a port put in and why she ultimately went forward with it. “Somehow, I felt that if I got the port, I was giving in to the cancer,” she writes.

A breast surgeon discusses what patients and their caregivers should know before breast cancer surgery.

Without a huge difference in efficacy between many of the available treatments for Waldenstrom’s macroglobulinemia, one expert says patients and their clinicians should look to other factors when deciding which regimen is best.

The TRANSCEND CLL 004 trial is currently enrolling patients to determine the efficacy of a CAR-T cell therapy.

Hypofractionated radiation for nearly five weeks in men with prostate cancer after surgery may have similar results without added side effects compared with radiation therapy for a standard duration of seven weeks.

Navigating discussions around treatments for early-stage breast cancer may be difficult, but feeling comfortable with one’s cancer team and knowing about all the available options may help.

A man reflects on slight symptoms he was not concerned about leading up to his prostate cancer diagnosis.

Twenty years after 9/11, a retired firefighter reflects on the weeks following the attacks, as well as his own diagnosis of lung cancer six years later, in a newly published book.

Looking deeper into mortality rates highlights the importance of eliminating disparities in lung cancer and expanding screening eligibility for at-risk populations.

"Having been newly diagnosed myself, I saw how amazingly well she was doing and had been a survivor for about three years already," a lung cancer survivor writes about a connection she made with another survivor.

A woman describes the grueling experience of watching cancer attack her sister's body and wishing she could stop it.

One patient details how her oncology nurse was the caring energy she needed when undergoing treatment for cancer.

The first patient with bladder cancer was dosed in a phase 1/2 trial examining responses to an investigational immunotherapy.

A pancreatic cancer survivor makes a comparison between alcoholism and being a cancer survivor.

The Food and Drug Administration granted approval to Besremi for the treatment of adults with polycythemia vera.

A patient with lung cancer explains how Terri Conneran, a patient advocate, helped her understand her disease and fight for proper care in a country with less options.

A lung cancer survivor shares a heartfelt tribute to Dr. Abraham Chachoua, who changed his life.

Two new FDA approvals for patients with lung cancer and EGFR exon 20 insertion mutations have given the subset its first targeted therapies.

A woman who has been living with metastatic breast cancer for seven years reflects on the strangeness of her body aging. “It’s the one thing I never imagined would happen after being diagnosed with and while living with a terminal illness – I’m actually getting old,” she writes.

From the death of Frederik Willem de Klerk to study results showing palm oil contains an acid that may cause cancer spread, here’s what’s happening in the cancer landscape this week.

Out of the darkness there is sometimes light, and in South Florida, Dr. Mark Block is a beacon of hope and light for many patients who’ve recently received a diagnosis of cancer.